Última actualización 29 de agosto de 2026
Key finding
Mean HbA1c decreased by 4.35 mmol/mol (P = 0.01)
Diani telemedicine system for diabetes management in patients with type 1 diabetes.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Extended (5–20+ y)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
Diani telemedicine system for diabetes management in patients with type 1 diabetes.
This study evaluated Diani telemedicine system for diabetes management in patients with type 1 diabetes.
Limitations were not clearly described in the extracted text.
Published in
Publication details and source links for this paper.
Amaryllis M, Chris M, Concetta I, et al. Evaluation of the Diani Telemedicine System for Patients with Type 1 Diabetes Mellitus: A Feasibility Study. JMIR Formative Research. 2023;7:e35064. doi:10.2196/35064
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Diani telemedicine system - Active Treatment and Blood glucose, Body weight, HbA1c, and 1 more.
This study contributes evidence to
Primary intervention
Diani telemedicine system - Active Treatment
Primary outcomes
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
5
Related topics
4
Evidence pairs
1993
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Tema de evidencia
matched_outcome
Evidencia relacionada
Tema de evidencia
Guardar evidencia
Core evidence
The primary outcomes reported in this study.
Diani telemedicine system - Active Treatment → Blood glucose
Diani telemedicine system - Active Treatment → Blood glucose
Diani telemedicine system - Active Treatment → Body weight
Diani telemedicine system - Active Treatment → Body weight
Diani telemedicine system - Active Treatment → HbA1c
Diani telemedicine system - Active Treatment → HbA1c
Diani telemedicine system - Active Treatment → Quality of life
Diani telemedicine system - Active Treatment → Quality of life
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Diani telemedicine system - Active Treatment and Fasting Glucose, Diani telemedicine system - Active Treatment and Body Weight.
This study contributes to the evidence on the following intervention-outcome relationships.
Devices & Technology
Devices & Technology
Devices & Technology
Curated evidence collections and hubs this study is part of.
All studies measuring Body Weight
Measures Body Weight as a key outcome.
All studies on Diani telemedicine system - Active Treatment
Contributes to Diani telemedicine system - Active Treatment evidence base.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
All studies measuring Quality of Life Outcomes
Measures Quality of Life Outcomes as a key outcome.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Diani telemedicine system - Active Treatment appears to lower HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear effect of Diani telemedicine system - Active Treatment on body weight.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Body weight
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Diani telemedicine system - Active Treatment for quality of life.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Quality of life
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Diani telemedicine system - Active Treatment may worsen blood glucose or be associated with harm.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Blood glucose
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Centrada en la evidencia, no en la publicidad.
Tus datos siempre están protegidos.
Se agregan nuevos estudios todos los días.
